1-8 of 8
Liyuan Qiu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nanobody-based Naturally Selected CD7-Targeted CAR-T Therapy for Acute Myeloid Leukemia

Clinical Trials & Observations
Peihua Lu, Xian Zhang, Junfang Yang, Jingjing Li, Liyuan Qiu, Meiwei Gong, Hui Wang, Jiaqi Chen, Hongxing Liu, Min Xiong, Ying Liu, Lin Wang
Journal: Blood
Blood blood.2024024861.
https://doi.org/10.1182/blood.2024024861
Published: 2024
Includes: Supplemental data
Journal Articles

CD7-Targeted CAR-T Cell Therapy Shows Promising Efficacy and Safety in Treating Refractory/Relapsed Peripheral T-Cell Lymphoma: Phase I Clinical Trial

Junfang Yang, Xian Zhang, Jingjing Li, Liyuan Qiu, Lin Wang, Peihua Lu
Journal: Blood
Blood (2024) 144 (Supplement 1): 2075.
https://doi.org/10.1182/blood-2024-196853
Published: 2024
Journal Articles

Naturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Acute Myeloid Leukemia: Phase I Clinical Trial

Xian Zhang, Junfang Yang, Jingjing Li, Liyuan Qiu, Hongxing Liu, Sr., Min Xiong, Jianqiang Li, Peihua Lu
Journal: Blood
Blood (2023) 142 (Supplement 1): 218.
https://doi.org/10.1182/blood-2023-179086
Published: 2023
Journal Articles

Analysis of 53 Patients with Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) Treated with CD7-Targeted CAR-T Cell Therapy

Xian Zhang, Junfang Yang, Jingjing Li, Liyuan Qiu, Jianqiang Li, Peihua Lu
Journal: Blood
Blood (2022) 140 (Supplement 1): 2369–2370.
https://doi.org/10.1182/blood-2022-158878
Published: 2022
Journal Articles

A Novel Universal CD7-Targeted CAR-T Cell Therapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma

Xian Zhang, Yali Zhou, Junfang Yang, Jingjing Li, Liyuan Qiu, Wengang Ge, Bo Pei, Jie Chen, Lu Han, Jiangtao Ren, Peihua Lu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4566–4567.
https://doi.org/10.1182/blood-2022-165733
Published: 2022
Journal Articles

Evolution and Proliferation of CD7 CAR-T Cells Compared to CD19 CAR-T Cells Therapies for Acute Leukemia

Xian Zhang, Gailing Zhang, Wenqian Li, Liyuan Qiu, Dongchu Wang, Junfang Yang, Jingjing Li, Peihua Lu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2820.
https://doi.org/10.1182/blood-2021-149978
Published: 2021
Journal Articles

Feasibility, and Efficacy of Donor-Derived cd19-Targeted Car t-Cell Therapy in Refractory/Relapsed(r/r)b-Cell Acute Lymphoblastic Leukemia (b-all) Patients

Xian Zhang, MD, Junfang Yang, Wenqian Li, Gailing Zhang, MD, Yunchao Su, Yanze Shi, Dan Song, Min Zhang, Jiujiang He, Li Xu, Liyuan Qiu, Xin-An Lu, Fei Wu, Jianqiang Li, PhD, Dandan Chen, Xiangqun Li, Ziyu Li, Jingjing Li, Peihua Lu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–6.
https://doi.org/10.1182/blood-2020-137299
Published: 2020
Journal Articles

Detecting 24 Kinds of Cytokines Via Flow Cytometry Aimplex Kit Is an Effective Way to Monitor CRS after CAR-T Cells Infusion

Dongchu Wang, Xiang Li, Liyuan Qiu, Shizhe Fu, Lingyun Cui, Hui Wang, MD, Peihua Lu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 50–51.
https://doi.org/10.1182/blood-2020-138404
Published: 2020